• CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries.

    Founded in 1998, CORMCO's mission is to deploy patient capital and generate superior long-term investment returns while embracing stringent risk management methodologies. CORMCO's public equity portfolio applies a fundamentally oriented and long-term investment approach. CORMCO's private equity portfolio invests in tech, biotech, and real estate growth companies already backed by solid institutional funding (pre-IPO equity and post-IPO equity).

     

    From 1998 to 2024, CORMCO’s investments generated a 21%annualized return, significantly outperforming the S&P 500 and Nasdaq Composite indexes' annualized returns over the same time period (respectively 10% and 14%). In addition to its own capital, CORMCO has access to over $10 billion through its strategic funding partnerships, paving the way for stellar global investment opportunities.

     

    CORMCO's net asset value (NAV) is calculated based on the net asset values of its public and private investments. CORMCO's revenue is the aggregate revenue of income stemming from portfolio properties, dividends paid out by portfolio companies, and fees generated by INCO Capital. CORMCO carries no debt and no leverage. From its inception in 1998 throughout the present day, CORMCO is backed by some of the most respected and influential investors, UHNW individuals, and institutions. CORMCO's stellar team makes sure CORMCO outperforms its peers in its areas of focus, remains at the forefront of innovation, and continues to deliver consistent and superior returns.

     

    Meet the CORMCO team

     

    Follow CORMCO on LinkedIn